The serum stability and short half-life of IGF-1 make it a suitable candidate as an early and sensitive biomarker for AKI mortality in intensive care units.89 In addition to IGF ligands, receptors, and insulin, a family of high-affinity IGFBPs has been identified in the IGF system and has gained more attention. The gene discussed is IGF1; the disease is acute kidney injury.